r.restrepo
TL2 Moderator · Tours
Contributes reviews on supplier material. Based in Tours.
Joined 5 March 2025 · last posted 22h
79 posts, newest first. Showing up to 150.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #131 · Evidence › Journal club · 27 Jul 2026 · 12 likes On post #127 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Here for the analytics and not much else Replied, post #101 · Lounge › Introductions · 27 Jul 2026 · 7 likes This follows post #98 rather than contradicting it. Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #126 · Sourcing › Independent verification · 26 Jul 2026 · 0 likes post #125 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #121 · Analytics › Home & field testing · 24 Jul 2026 · 10 likes Picking up post #118: that is the part I would want checked first. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result.…
-
Pooling trials with different estimands Replied, post #119 · Evidence › Meta-analyses · 22 Jul 2026 · 0 likes post #118 answers the question as asked. The question underneath it is different. Number needed to treat from a meta-analysis: can be computed from the pooled estimate…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #50 · Pharmacology › Receptor biology · 20 Jul 2026 · 10 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #70 · Practice › Administration · 14 Jul 2026 · 1 like Coming back to post #68, because the follow-up matters more than the original answer. Injecting into an area that has become firm: lipohypertrophy — thickened fatty…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #30 · Practice › Interactions · 10 Jul 2026 · 26 likes Worth separating two things that post #26 runs together. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual,…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #43 · Evidence › Journal club · 9 Jul 2026 · 29 likes post #42 answers the question as asked. The question underneath it is different. Session format: read the paper before posting. The discussion is much better when…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #63 · Analytics › Method validation · 22 Jun 2026 · 0 likes Picking up post #60: that is the part I would want checked first. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #50 · Compounds › Tirzepatide · 21 Jun 2026 · 0 likes This follows post #47 rather than contradicting it. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #13 · Access › Shortages · 14 Jun 2026 · 9 likes Worth separating two things that post #9 runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply…
-
Follow-up: Search filters: what is missing Replied, post #126 · Meta › Site feedback · 11 Jun 2026 · 22 likes post #125 is right about the mechanism and I think understates the practical bit. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently,…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #31 · Wellbeing › Sleep · 7 Jun 2026 · 4 likes This follows post #28 rather than contradicting it. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #28 · Access › Pricing · 24 May 2026 · 1 like I read post #26 twice before replying, because I had assumed the opposite. International pricing: the same compound costs very different amounts in different countries…
-
Run-in periods and the population they select Replied, post #123 · Evidence › Trials · 24 May 2026 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #17 · Practice › Reconstitution · 21 May 2026 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #51 · Evidence › Journal club · 8 May 2026 · 11 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
System suitability injections: if they failed, the run did not happen — the long version Replied, post #3 · Analytics › HPLC & UHPLC · 6 May 2026 · 8 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Blind submission and why it changes minds — the long version Replied, post #33 · Sourcing › Independent verification · 21 Apr 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #46 · Sourcing › Vendor reports · 5 Apr 2026 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #86 · Clinical › Special populations · 26 Mar 2026 · 0 likes Worth separating two things that post #82 runs together. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to…
-
Coming back to: Time to steady state after a dose increase Replied, post #18 · Pharmacology › Pharmacokinetics · 22 Mar 2026 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #12 · Practice › Side effects · 20 Mar 2026 · 1 like Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #38 · Compounds › Repair & healing peptides · 11 Mar 2026 · 2 likes Coming back to post #36, because the follow-up matters more than the original answer. Publication patterns in the BPC-157 literature: a large proportion of the evidence…
-
Second pass at: What pooling buys you and what it destroys Replied, post #25 · Evidence › Meta-analyses · 8 Mar 2026 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Coming back to: Training through a dose escalation week Replied, post #42 · Nutrition & Training › Resistance training · 3 Mar 2026 · 4 likes Coming back to post #40, because the follow-up matters more than the original answer. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable…
-
The lowest dose that does anything: is that a real question? Replied, post #17 · Practice › Dosing & titration · 2 Mar 2026 · 2 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Second pass at: Identical chromatograms across two different lots Replied, post #16 · Sourcing › Red flags · 19 Feb 2026 · 4 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #121 · Sourcing › Independent verification · 13 Feb 2026 · 15 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #8 · Compounds › Tirzepatide · 5 Feb 2026 · 0 likes Picking up post #5: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #56 · Clinical › Special populations · 24 Jan 2026 · 33 likes On post #52 — agreed on the reasoning, with one qualification. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll…
-
Adsorption to container surfaces and to plastics Replied, post #6 · Pharmacology › Formulation chemistry · 13 Jan 2026 · 0 likes Container closure: the vial material, rubber closure, and sealing all affect permeability to water and oxygen. Glass is less permeable than plastic. Rubber quality…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #25 · Practice › Side effects · 5 Jan 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Follow-up: Reconciling a label claim with a content assay Started this topic · Analytics › COA interpretation · 27 Dec 2025 · 0 likes Reconciling a label claim with a content assay Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #2 · Research Methods › Statistics · 23 Dec 2025 · 18 likes Coming back to the opening post, because the follow-up matters more than the original answer. Absence of evidence and evidence of absence: if a study is small and finds…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #10 · Compounds › Tirzepatide · 6 Nov 2025 · 20 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Batch date after test date, and other internal inconsistencies Replied, post #9 · Analytics › COA interpretation · 16 Oct 2025 · 3 likes I read post #7 twice before replying, because I had assumed the opposite. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin…
-
Temperature loggers worth the money Replied, post #41 · Devices › Cold chain · 13 Oct 2025 · 0 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Compounds this community declines to help with, and why Replied, post #51 · Compounds › Other compounds · 3 Oct 2025 · 3 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
A preprint whose numbers changed substantially at publication Replied, post #75 · Evidence › Preprints · 2 Oct 2025 · 10 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Pooling trials with different estimands — what changed since Replied, post #31 · Evidence › Meta-analyses · 30 Sep 2025 · 16 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Column chemistry choices for a 40-residue peptide Replied, post #37 · Analytics › HPLC & UHPLC · 15 Sep 2025 · 2 likes This follows post #34 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
Request: a diff view for wiki revisions — the long version Replied, post #38 · Meta › Feature requests · 3 Sep 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Canadian access and provincial variation — one year on Replied, post #16 · Regional › North America · 22 Jul 2025 · 22 likes On post #12 — agreed on the reasoning, with one qualification. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries'…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #81 · Compounds › Retatrutide · 18 Jul 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #25 · Start Here › How to Ask · 15 Jul 2025 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Pooling trials with different estimands — what changed since Replied, post #2 · Evidence › Meta-analyses · 7 Jul 2025 · 0 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Interim analyses and stopping rules — does this still hold? Replied, post #31 · Evidence › Trials · 4 Jul 2025 · 18 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #47 · Evidence › Trials · 27 Jun 2025 · 3 likes post #46 is right about the mechanism and I think understates the practical bit. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of…
-
Insulin combinations and hypoglycaemia risk Replied, post #18 · Practice › Interactions · 23 Jun 2025 · 30 likes This follows post #15 rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #61 · Clinical › Comorbidities · 10 Jun 2025 · 4 likes I read post #59 twice before replying, because I had assumed the opposite. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #38 · Nutrition & Training › Protein & intake · 7 Jun 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: What other technical communities get right that we do not Replied, post #123 · Lounge › Off topic · 7 Jun 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #101 · Outcomes › Body composition · 26 May 2025 · 15 likes Coming back to post #99, because the follow-up matters more than the original answer. Lean mass loss during rapid weight reduction: depends on protein intake,…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #60 · Wellbeing › Mental health · 12 May 2025 · 6 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Individual participant data versus aggregate data Replied, post #26 · Evidence › Meta-analyses · 10 Apr 2025 · 3 likes Coming back to post #24, because the follow-up matters more than the original answer. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Retatrutide dose escalation in the published trials Replied, post #104 · Compounds › Retatrutide · 8 Apr 2025 · 19 likes This follows post #101 rather than contradicting it. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #46 · Clinical › Comorbidities · 31 Mar 2025 · 2 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Requesting a page: what makes a good request Replied, post #8 · Documentation › Wiki requests · 25 Feb 2025 · 0 likes This follows post #5 rather than contradicting it. Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The…
-
Albumin binding and how it produces a long half-life Replied, post #9 · Pharmacology › Pharmacokinetics · 25 Feb 2025 · 1 like I read post #7 twice before replying, because I had assumed the opposite. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13…
-
Coming back to: Official shortage notices and what they authorise Replied, post #14 · Access › Shortages · 12 Feb 2025 · 18 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #50 · Analytics › Mass spectrometry · 7 Feb 2025 · 18 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #43 · Wellbeing › Mental health · 27 Jan 2025 · 16 likes post #42 answers the question as asked. The question underneath it is different. Body image and weight loss: large weight loss changes a person's relationship with…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #79 · Compounds › Semaglutide · 7 Jan 2025 · 6 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
When "no data" is the complete and final answer Replied, post #32 · Compounds › Other compounds · 1 Dec 2024 · 16 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Fixed versus detachable needles: the trade-offs Replied, post #21 · Devices › Syringes & needles · 27 Nov 2024 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #2 · Nutrition & Training › Resistance training · 31 Oct 2024 · 9 likes Worth separating two things that the opening post runs together. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving…
-
Requesting a page: what makes a good request — what changed since Replied, post #52 · Documentation › Wiki requests · 11 Oct 2024 · 20 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Progressive overload when the scale is falling — one year on Replied, post #110 · Nutrition & Training › Resistance training · 1 Oct 2024 · 32 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #14 · Compounds › Other compounds · 23 Sep 2024 · 20 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #51 · Evidence › Journal club · 22 Sep 2024 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #38 · Clinical › Bloodwork · 18 Sep 2024 · 6 likes Coming back to post #36, because the follow-up matters more than the original answer. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #20 · Compounds › Oral incretins · 29 Aug 2024 · 16 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Correlation in a self-tracked dataset: what it can support Replied, post #76 · Research Methods › Statistics · 23 Aug 2024 · 0 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #37 · Analytics › COA interpretation · 10 Aug 2024 · 14 likes Picking up post #34: that is the part I would want checked first. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #4 · Compounds › Oral incretins · 14 Jul 2024 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #91 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Assessing a warm arrival: the decision process — one year on Replied, post #72 · Sourcing › Logistics · 31 May 2024 · 11 likes Coming back to post #70, because the follow-up matters more than the original answer. At what point is a parcel genuinely a problem: if it was despatched weeks ago and…